Critical role of Spns2, a sphingosine-1-phosphate transporter, in lung cancer cell survival and migration

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Bradley, Eric ^a   Dasgupta, Somsankar ^a   Jiang, Xue ^b   Zhao, Xiaying ^a   Zhu, Gu ^a   He, Qian ^a   Dinkins, Michael ^a   Bieberich, Erhard ^a   Wang, Guanghu ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; STAT3 PROTEIN; ANION TRANSPORT PROTEIN; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; SPNS2 PROTEIN, HUMAN;

ADVANCED CANCER; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INDUCTION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; REGULATOR GENE; SPNS2 GENE; ANALOGS AND DERIVATIVES; ANIMAL; CELL MOTION; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; INTRACELLULAR SPACE; LUNG TUMOR; METABOLISM; MOUSE; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; ANION TRANSPORT PROTEINS; APOPTOSIS; BIOLOGICAL TRANSPORT; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRACELLULAR SPACE; LUNG NEOPLASMS; LYSOPHOSPHOLIPIDS; MICE; RECEPTORS, LYSOSPHINGOLIPID; RNA, MESSENGER; SPHINGOSINE;

EID: 84908191417     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110119     Document Type: Article

References (50)

1. Herbst RS, Heymach JV, Lippman S.M. (2008) Lung cancer. N Engl J Med 359: 1367-1380.
2. West L, Vidwans SJ, Campbell N.P., Shrager J., Simon GR, et al. (2012) A novel classification of lung cancer into molecular subtypes. PLoS One 7: e31906.
3. American-Cancer-Society (2012) Cancer Facts & Figures 2012. Atlanta.
4. Heist RS, Sequist LV, Engelman J.A. (2012) Genetic changes in squamous cell lung cancer: a review. J Thorac Oncol 7: 924-933.
5. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan E.H., Hirsh V., et al. (2005) Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353: 123-132.
6. Kwak EL, Bang YJ, Camidge D.R., Shaw AT, Solomon B, et al. (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363: 1693-1703.
7. Zhu WG, Lakshmanan RR, Beal M.D., Otterson G.A. (2001) DNA methyltrans-ferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Cancer Res 61: 1327-1333.
8. Shinjo K, Kondo Y. (2012) Clinical implications of epigenetic alterations in human thoracic malignancies: epigenetic alterations in lung cancer. Methods Mol Biol 863: 221-239.
9. Nakata A, Gotoh N. (2012) Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer. Expert Opin Ther Targets 16: 771-781.
10. Huang YL, Huang WP, Lee H. (2011) Roles of sphingosine 1-phosphate on tumorigenesis. World J Biol Chem 2: 25-34.
11. Spiegel S, Milstien S. (2011) The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 11: 403-415.
12. Spiegel S, Cuvillier O, Edsall L., Kohama T, Menzeleev R, et al (1998) Roles of sphingosine-1-phosphate in cell growth, differentiation, and death. Biochemistry (Mosc) 63: 69-73.
13. Chalfant CE, Spiegel S. (2005) Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci 118: 4605-4612.
14. Takuwa N, Du W, Kaneko E., Okamoto Y, Yoshioka K, et al (2011) Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde. Am J Cancer Res 1: 460-481.
15. Nagahashi M, Ramachandran S, Kim E.Y., Allegood JC, Rashid OM, et al. (2012) Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res 72: 726-735.
16. Cuvillier O (2008) Downregulating sphingosine kinase-1 for cancer therapy. Expert Opin Ther Targets 12: 1009-1020.
17. Brizuela L, Ader I, Mazerolles C., Bocquet M, Malavaud B, et al (2012) First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer. Mol Cancer Ther 11: 1841-1851.
18. Hisano Y, Nishi T, Kawahara A. (2012) The functional roles of S1P in immunity. J Biochem 152: 305-311.
19. Novgorodov AS, El-Alwani M, Bielawski J., Obeid LM, Gudz T.I. (2007) Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J 21: 1503-1514.
20. Maceyka M, Harikumar KB, Milstien S, Spiegel S. (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22: 50-60.
21. Alberg AJ, Armeson KE, Pierce J.S., Bielawski J., Bielawska A, et al. (2013) Plasma sphingolipids as markers of future lung cancer risk: A population-based, nested case-control study. Cancer Epidemiol Biomarkers Prev.
22. Tanfin Z, Serrano-Sanchez M, Leiber D. (2011) ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium. Cell Signal 23: 1997-2004.
23. Kobayashi N, Yamaguchi A, Nishi T. (2009) Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J Biol Chem 284: 21192-21200.
24. Sato K, Malchinkhuu E, Horiuchi Y., Mogi C, Tomura H, et al (2007) Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes. J Neurochem 103: 2610-2619.
25. Takabe K, Kim RH, Allegood J.C., Mitra P., Ramachandran S, et al. (2010) Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem 285: 10477-10486.
26. Mitra P, Oskeritzian CA, Payne S.G., Beaven MA, Milstien S, et al. (2006) Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci U S A 103: 16394-16399.
27. Hisano Y, Kobayashi N, Kawahara A., Yamaguchi A, Nishi T. (2011) The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. J Biol Chem 286: 1758-1766.
28. Lee YM, Venkataraman K, Hwang S.I., Han DK, Hla T. (2007) A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatog-raphy (IMAC). Prostaglandins Other Lipid Mediat 84: 154-162.
29. Hisano Y, Kobayashi N, Yamaguchi A., Nishi T. (2012) Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS One 7: e38941.
30. Nijnik A, Clare S, Hale C., Chen J, Raisen C, et al (2012) The role of sphingosine-1-phosphate transporter Spns2 in immune system function. J Immunol 189: 102-111.
31. Kawahara A, Nishi T, Hisano Y., Fukui H, Yamaguchi A, et al (2009) The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science 323: 524-527.
32. Fukuhara S, Simmons S, Kawamura S., Inoue A, Orba Y, et al (2012) The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J Clin Invest 122: 1416-1426.
33. Nagahashi M, Kim EY, Yamada A, Ramachandran S., Allegood JC, et al. (2012) Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels and the lymphatic network. FASEB J.
34. Mendoza A, Breart B, Ramos-Perez WD, Pitt L.A., Gobert M., et al. (2012) The transporter spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Rep 2: 1104-1110.
35. Wang G, Krishnamurthy K, Tangpisuthipongsa D. (2011) Protection of murine neural progenitor cells by the Hsp90 inhibitor 17-allylamino-17-demethoxygel-danamycin in the low nanomolar concentration range. J Neurochem 117: 703-711.
36. Bradley E, Bieberich E, Mivechi N.F., Tangpisuthipongsa D., Wang G. (2012) Regulation of embryonic stem cell pluripotency by heat shock protein 90. Stem Cells 30: 1624-1633.
37. Wang G, Dinkins M, He Q., Zhu G, Poirier C, et al (2012) Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem 287: 21384-21395.
38. Wang G, Krishnamurthy K, Umapathy N.S., Verin AD, Bieberich E. (2009) The carboxyl-terminal domain of atypical protein kinase Czeta binds to ceramide and regulates junction formation in epithelial cells. J Biol Chem 284: 14469-14475.
39. Wang G, Ying Z, Jin X., Tu N, Zhang Y, et al (2004) Essential requirement for both hsf1 and hsf2 transcriptional activity in spermatogenesis and male fertility. Genesis 38: 66-80.
40. Wang G, Silva J, Dasgupta S., Bieberich E. (2008) Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes. Glia 56: 449-456.
41. Wang G, Silva J, Krishnamurthy K., Bieberich E. (2006) A novel isoform of prostate apoptosis response 4 (PAR-4) that co-distributes with F-actin and prevents apoptosis in neural stem cells. Apoptosis 11: 315-325.
42. Wang G, Krishnamurthy K, Chiang Y.W., Dasgupta S., Bieberich E. (2008) Regulation of neural progenitor cell motility by ceramide and potential implications for mouse brain development. J Neurochem 106: 718-733.
43. Bielawski J, Szulc ZM, Hannun Y.A., Bielawska A. (2006) Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods (San Diego, Calif) 39: 82-91.
44. Ambrosini G, Adida C, Altieri D.C. (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921.
45. Yano A, Tsutsumi S, Soga S., Lee MJ, Trepel J, et al. (2008) Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone. Proc Natl Acad Sci U S A 105: 15541-15546.
46. Looyenga BD, Hutchings D, Cherni I., Kingsley C, Weiss GJ, et al (2012) STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma. PloS one 7: e30820.
47. Teng TS, Lin B, Manser E., Ng DC, Cao X. (2009) Stat3 promotes directional cell migration by regulating Rac1 activity via its activator betaPIX. J Cell Sci 122: 4150-4159.
48. Berdyshev EV, Gorshkova I, Usatyuk P., Kalari S, Zhao Y, et al (2011) Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. PLoS One 6: e16571.
49. Jope RS, Yuskaitis CJ, Beurel E. (2007) Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 32: 577-595.
50. Osborne N, Brand-Arzamendi K, Ober E.A., Jin SW, Verkade H, et al. (2008) The spinster homolog, two of hearts, is required for sphingosine 1-phosphate signaling in zebrafish. Curr Biol 18: 1882-1888.